Spero Therapeutics (SPRO) Assets Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.05% |
| Dec 31, 2025 | -37.65% |
| Sep 30, 2025 | -59.92% |
| Jun 30, 2025 | -58.55% |
| Mar 31, 2025 | -53.66% |
| Dec 31, 2024 | -39.39% |
| Sep 30, 2024 | 26.20% |
| Jun 30, 2024 | 51.57% |
| Mar 31, 2024 | 49.01% |
| Dec 31, 2023 | 46.14% |
| Sep 30, 2023 | 66.11% |
| Jun 30, 2023 | 55.41% |
| Mar 31, 2023 | -22.82% |
| Dec 31, 2022 | -27.05% |
| Sep 30, 2022 | -55.44% |
| Jun 30, 2022 | -46.80% |
| Mar 31, 2022 | 1.67% |
| Dec 31, 2021 | 11.48% |
| Sep 30, 2021 | -7.86% |
| Jun 30, 2021 | 22.60% |
| Mar 31, 2021 | 30.53% |
| Dec 31, 2020 | 44.62% |
| Sep 30, 2020 | 39.58% |
| Jun 30, 2020 | -20.36% |
| Mar 31, 2020 | -11.84% |
| Dec 31, 2019 | -17.75% |
| Sep 30, 2019 | -17.34% |
| Jun 30, 2019 | 68.74% |
| Mar 31, 2019 | 53.78% |
| Dec 31, 2018 | 38.01% |
| Sep 30, 2018 | 331.44% |
| Dec 31, 2017 | 578.76% |